Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III .

Kalshi, a prediction market platform, has raised a $185 million investment round, pushing its valuation to $2 billion.

Despite major advances, real-world data show diminishing survival outcomes and treatment-limiting toxicities in second line ...

Kalshi founder Tarek Mansour announced on Wednesday that the online trading company that offers sports outcome contracts ...

Kalshi raises $185M at $2B valuation, signaling prediction market maturity and crypto sector growth amid regulatory challenges.

Kalshi achieved unicorn status following its latest Series C funding round, amid the prediction markets platform's growing ...

GTE raised $15M in Series A funding led by Paradigm, aiming to become the fastest decentralized exchange and rival major ...

A new DEX called GTE has received funding support to beat the existing CEXs and DEXs using its CLOB model. Can it overcome ...

Paradigm has filed an amicus brief arguing the jury in the case against Tornado Cash co-founder Roman Storm needs clarity on ...